Latest News
Latest News
Patients with COVID-19 may face risk for liver injury
Mechanisms of damage remain unclear, but could include virus-, immune-, or drug-induced injury.
Feature
COVID-19 will test medical supply stocks
“In the matter of a week or two...I think we’ll get a feel for whether or not we really have enough of the supplies that it takes,” said Dr....
From the Journals
COVID-19 in China: Children have less severe disease, but are vulnerable
The findings of this case review underscore the possibility that children “may play a major role in community-based viral transmission” of novel...
Latest News
ACP outlines guide for COVID-19 telehealth coding, billing
Also included are tips on handling staff absences and information on allowed technology and services.
Latest News
Clinicians petition government for national quarantine
The petition was started by an apolitical Facebook group to focus attention on what members see as the most critical issues for clinicians.
Latest News
COVID-19: U.S. cardiology groups reaffirm continued use of RAAS-active drugs
Experts give ACE inhibitors and ARBs, cornerstones of cardiology therapy, a thumbs up despite a hypothetical adverse COVID-19 effect.
From the Journals
HPV vaccine-chemo combo prolongs cervical cancer survival
Longer survival was observed in women with a stronger immune response to human papillomavirus vaccination during chemotherapy.
Opinion
COVID-19 guidance for children’s health care providers
Accurate information calmly delivered is the antidote to anxiety or panic in a stressful situation.
Latest News
Prospective algorithm favors vaginal hysterectomy
A decision tree model and outcomes analysis showed vaginal surgery as safe, effective, and feasible.
Latest News
Physicians and health systems can reduce fear around COVID-19
“We must look after our patients. But we also have to look after ourselves so that we can look after our patients,” said Dr. Peter M. Yellowlees...
News
FDA advises stopping SGLT2 inhibitor treatment prior to surgery
The changes affect canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, and were made because surgery may put patients taking SGLT2...